InvestorsHub Logo
Followers 60
Posts 7404
Boards Moderated 0
Alias Born 10/20/2014

Re: biowreck post# 122413

Saturday, 02/10/2018 11:37:06 AM

Saturday, February 10, 2018 11:37:06 AM

Post# of 426715
So long as AMRN stays with the "go it alone" strategy they will be doing
additional stock offerings. AMRN management has stated they plan to diversify their product offerings by acquiring other drug candidates.
The only way this will end is if Vascepa is wildly successful or they
accept a takeover offer by BP. I am confidant enough about Vascepa's
prospects that none of this is of concern.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News